SUPPRESSION OF CORPUS-LUTEUM FUNCTION BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST NAL-GLU - EFFECT OF THE DOSE AND TIMING OF HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION

被引:0
|
作者
DUBOURDIEU, S
CHARBONNEL, B
MASSAI, MR
MARRAOUI, J
SPITZ, I
BOUCHARD, P
机构
[1] CTR BIOMED RES,POPULAT COUNCIL,NEW YORK,NY
[2] HOP BICETRE,SERV ENDOCRINOL,F-94270 LE KREMLIN BICETR,FRANCE
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the effect of gonadotropin-releasing hormone antagonist Nal-Glu administration in the luteal phase and the potential rescue by exogenous human chorionic gonadotropin (hCG) of corpus luteum (CL) after antagonist treatment. Design: We studied the dose of Nal-Glu required for luteolysis and subsequently we coadministered low doses of hCG for 3 consecutive days either simultaneously to Nal-Glu administration (n = 5), or 48 (n = 5), or 72 hours (n = 5) later. Six additional participants received pharmacological doses of hCG 48 hours after the luteolytic dose of Nal-Glu. Setting: Participants were studied in Clinique Endocrinologique, Nantes, and in Service d'Endocrinologie, Ho triple-overdot ital Bice triple-overdot tre, Le Kremlin Bicetre, France. Participants: Twenty-nine normal young women (ages 20 to 35) were studied. Interventions: None. Main Outcome Measure: Measurements of follicle-stimulating hormone, luteinizing hormone (LH), estradiol, Progesterone (P) levels were performed by radioimmunoassay before, during, and after the various treatment regimens. Results: Complete luteolysis occurred in women who received 10 mg of Nal-Glu daily on days 4 and 5 after the LH surge. The coadministration of Nal-Glu and hCG overrode the effect of the antagonist (P = 48.8 +/- 22.5 versus 60.8 +/- 3.1 nmol/L in controls treated with hCG alone [NS]). When hCG treatment was started 48 hours after Nal-Glu, a partial luteolysis occurred (P = 33.8 +/- 10.9 versus 117 +/- 12.9 nmol/L, P < 0.01). When hCG was started 72 hours after Nal-Glu, a complete luteolysis occurred (P = 5.8 +/- 2.05 versus 36.2 +/- 0.6 nmol/L, P < 0.01). Higher doses of hCG (1,500 or 5,000 IU) administered 72 hours after Nal-Glu resulted in a significant rescue of CL function (P = 37.7 +/- 4.8 and P = 43.8 +/- 22.2 versus 74.5 +/- 19.8 and 130.2 +/- 14.3 nmol/L, P < 0.05), respectively. Conclusions: These results confirm the LH dependence of CL function. The suppression of CL LH support for 72 hours induced a compromise of the CL nonreversible by low doses of hCG mimicking early pregnancy but reversible with pharmacological doses.
引用
收藏
页码:440 / 445
页数:6
相关论文
共 50 条
  • [21] GONADOTROPIN-RELEASING-HORMONE AND CHORIONIC-GONADOTROPIN GENE-EXPRESSION IN HUMAN PLACENTAL DEVELOPMENT
    KELLY, AC
    RODGERS, A
    DONG, KW
    BARREZUETA, NX
    BLUM, M
    ROBERTS, JL
    DNA AND CELL BIOLOGY, 1991, 10 (06) : 411 - 421
  • [22] EFFICACY OF HUMAN CHORIONIC-GONADOTROPIN AND GONADOTROPIN-RELEASING-HORMONE FOR HASTENING OVULATION IN THOROUGHBRED MARES
    MICHEL, TH
    ROSSDALE, PD
    CASH, RSG
    EQUINE VETERINARY JOURNAL, 1986, 18 (06) : 438 - 442
  • [23] IMPAIRED CORPUS-LUTEUM FUNCTION IN ECTOPIC PREGNANCY CANNOT BE EXPLAINED BY ALTERED HUMAN CHORIONIC-GONADOTROPIN
    NORMAN, RJ
    BUCK, RH
    KEMP, MA
    JOUBERT, SM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (06): : 1166 - 1170
  • [24] SPONTANEOUS LUTEINIZING-HORMONE SURGES CAN BE RELIABLY PREVENTED BY THE TIMELY ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (NAL-GLU) DURING THE LATE FOLLICULAR PHASE
    FRYDMAN, R
    CORNEL, C
    DEZIEGLER, D
    TAIEB, J
    SPITZ, IM
    BOUCHARD, P
    HUMAN REPRODUCTION, 1992, 7 (07) : 930 - 933
  • [25] GONADOTROPIN-RELEASING-HORMONE INCREASES SERUM HUMAN CHORIONIC-GONADOTROPIN IN PREGNANT-WOMEN
    IWASHITA, M
    KUDO, Y
    SHINOZAKI, Y
    TAKEDA, Y
    ENDOCRINE JOURNAL, 1993, 40 (05) : 539 - 544
  • [26] EFFECT OF HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION ON PITUITARY AND LUTEAL RESPONSE TO GONADOTROPIN-RELEASING HORMONE
    LANZONE, A
    FULGHESU, AM
    DISIMONE, N
    APA, R
    GUIDA, C
    CARUSO, A
    MANCUSO, S
    HORMONE RESEARCH, 1989, 32 (5-6) : 203 - 207
  • [27] THE IMPORTANCE OF HUMAN CHORIONIC-GONADOTROPIN SUPPORT OF THE CORPUS-LUTEUM DURING HUMAN GONADOTROPIN THERAPY IN WOMEN WITH ANOVULATORY INFERTILITY
    MESSINIS, IE
    BERGH, T
    WIDE, L
    FERTILITY AND STERILITY, 1988, 50 (01) : 31 - 35
  • [28] PERSISTENT VERSUS TRANSIENT STIMULATION OF THE MACAQUE CORPUS-LUTEUM DURING PROLONGED EXPOSURE TO HUMAN CHORIONIC-GONADOTROPIN - A FUNCTION OF AGE OF THE CORPUS-LUTEUM
    OTTOBRE, JS
    STOUFFER, RL
    ENDOCRINOLOGY, 1984, 114 (06) : 2175 - 2182
  • [29] Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone
    Swerdloff, RS
    Bagatell, CJ
    Wang, C
    Anawalt, BD
    Berman, N
    Steiner, B
    Bremner, WJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10): : 3527 - 3533
  • [30] THE EFFECT OF INTRALUTEAL INFUSION OF DEGLYCOSYLATED HUMAN CHORIONIC-GONADOTROPIN ON THE CORPUS-LUTEUM IN RHESUS-MONKEYS
    PATTON, PE
    STOUFFER, RL
    ZELINSKIWOOTEN, MB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04): : 1213 - 1218